How many insider declarations has Readnour Robin Shane filed?

Readnour Robin Shane has filed 1 public insider declaration with SEC (Form 4).

What is Readnour Robin Shane's role?

Readnour Robin Shane's reported role is not specified by the regulator across the filings.

Which companies does Readnour Robin Shane report trades for?

Readnour Robin Shane reports trades for AN2 Therapeutics, Inc..

← Executives ★ Sign in to follow

RR

Readnour Robin Shane

·SEC (Form 4)

AN2 Therapeutics, Inc.

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Discover the detailed record of transactions filed by Readnour Robin Shane. Director active across 1 company, notably AN2 Therapeutics, Inc.. Cumulatively, 1 disclosures have been recorded. History available since 17 August 2026. The latest transaction was filed on 17 August 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). The full history is openly available.

Companies and markets linked to Readnour Robin Shane

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

AN2 Therapeutics, Inc. (US)

Declarations1 total

●

Readnour Robin Shane

DirectorExecutives17 Aug 2026AN2 Therapeutics, Inc.

$6M0Source ↗

1,012,000 shares@ US$6.0082Common StockSEC144:0001972481-26-000263

1 of 1 declaration

InsidersTradesSigma

← Executives ★ Sign in to follow

RR

Readnour Robin Shane

·SEC (Form 4)

AN2 Therapeutics, Inc.

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Discover the detailed record of transactions filed by Readnour Robin Shane. Director active across 1 company, notably AN2 Therapeutics, Inc.. Cumulatively, 1 disclosures have been recorded. History available since 17 August 2026. The latest transaction was filed on 17 August 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). The full history is openly available.